HK1021623A1 - Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases. - Google Patents
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases.Info
- Publication number
- HK1021623A1 HK1021623A1 HK00100645A HK00100645A HK1021623A1 HK 1021623 A1 HK1021623 A1 HK 1021623A1 HK 00100645 A HK00100645 A HK 00100645A HK 00100645 A HK00100645 A HK 00100645A HK 1021623 A1 HK1021623 A1 HK 1021623A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cyclooxygenase
- compositions
- once
- mediated diseases
- day treatment
- Prior art date
Links
- 102000010907 Cyclooxygenase 2 Human genes 0.000 title 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1787896P | 1996-05-17 | 1996-05-17 | |
| GBGB9612063.9A GB9612063D0 (en) | 1996-06-10 | 1996-06-10 | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases |
| PCT/US1997/008041 WO1997044028A1 (en) | 1996-05-17 | 1997-05-13 | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1021623A1 true HK1021623A1 (en) | 2000-06-23 |
Family
ID=26309472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK00100645A HK1021623A1 (en) | 1996-05-17 | 2000-02-02 | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6063811A (hu) |
| EP (1) | EP0910368A1 (hu) |
| JP (1) | JPH11512754A (hu) |
| KR (1) | KR100373622B1 (hu) |
| CN (1) | CN1140267C (hu) |
| AR (1) | AR012014A1 (hu) |
| AU (1) | AU3004997A (hu) |
| BG (1) | BG103000A (hu) |
| BR (1) | BR9709097A (hu) |
| CA (1) | CA2254061C (hu) |
| CO (1) | CO5050370A1 (hu) |
| CZ (1) | CZ291463B6 (hu) |
| DZ (1) | DZ2200A1 (hu) |
| EA (1) | EA001596B1 (hu) |
| EE (1) | EE03746B1 (hu) |
| HK (1) | HK1021623A1 (hu) |
| HR (1) | HRP970262A2 (hu) |
| HU (1) | HUP9902889A3 (hu) |
| ID (1) | ID16921A (hu) |
| IL (1) | IL126899A (hu) |
| IS (1) | IS4891A (hu) |
| MY (1) | MY116201A (hu) |
| NO (1) | NO985342D0 (hu) |
| NZ (1) | NZ332670A (hu) |
| PE (1) | PE66998A1 (hu) |
| PL (1) | PL188649B1 (hu) |
| SK (1) | SK284330B6 (hu) |
| TR (1) | TR199802345T2 (hu) |
| WO (1) | WO1997044028A1 (hu) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002506024A (ja) * | 1998-03-13 | 2002-02-26 | メルク エンド カムパニー インコーポレーテッド | 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物 |
| US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
| SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
| CO5190664A1 (es) | 1999-06-30 | 2002-08-29 | Pfizer Prod Inc | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 |
| GB9920558D0 (en) * | 1999-08-31 | 1999-11-03 | Bradford Particle Design Ltd | Methods for particle formation and their products |
| EP1239856A1 (en) * | 1999-12-22 | 2002-09-18 | Pharmacia Corporation | Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| CN100588395C (zh) | 2000-06-13 | 2010-02-10 | Wyeth公司 | 含有环氧化酶-2抑制剂的止痛和抗炎药物 |
| MXPA03001407A (es) * | 2000-08-18 | 2003-06-06 | Pharmacia Corp | Formulacion oral de desintegracion rapida de un inhibidor de ciclooxigenasa-2. |
| CN1638739A (zh) * | 2000-08-18 | 2005-07-13 | 法玛西雅厄普约翰美国公司 | 治疗成瘾性障碍的化合物 |
| WO2002017896A2 (en) * | 2000-08-29 | 2002-03-07 | Peter Van Patten | Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid |
| AR030630A1 (es) * | 2000-09-11 | 2003-08-27 | Novartis Ag | Composiciones farmaceuticas |
| US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| AU2002303577B2 (en) * | 2001-05-04 | 2006-06-08 | Merck & Co., Inc. | Method and compositions for treating migraines |
| PE20030323A1 (es) * | 2001-08-31 | 2003-05-12 | Novartis Ag | Composicion farmaceutica |
| EP1490035A1 (en) * | 2001-09-26 | 2004-12-29 | Pharmacia Corporation | Intraorally disintegrating valdecoxib compositions |
| MXPA04003404A (es) * | 2001-10-10 | 2004-06-18 | Pharmacia Corp | Composiciones de valdecoxib de disgregacion intraoral preparadas mediante un procedimiento de desecacion por pulverizacion. |
| CA2476744A1 (en) * | 2002-03-07 | 2003-09-12 | Novartis Ag | Solid pharmaceutical compositions comprising lumiracoxib |
| ES2213485B1 (es) | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | Derivados de la 2-fenilpiran-4-ona. |
| ES2214129B1 (es) * | 2003-02-13 | 2005-12-01 | Almirall Prodesfarma, S.A. | 3-fenilfuran-2-onas. |
| AU2004237439B2 (en) | 2003-05-07 | 2009-09-10 | Osteologix A/S | Treating cartilage/bone conditions with water-soluble strontium salts |
| TR200301552A1 (tr) * | 2003-09-18 | 2005-10-21 | Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Rofekoksib' in yeni oral farmakolojik formülasyonları. |
| CN101626787A (zh) * | 2007-01-19 | 2010-01-13 | 马林克罗特公司 | 诊断的和治疗的环氧合酶-2结合配体 |
| EP3883562A4 (en) | 2018-11-21 | 2022-08-03 | Tremeau Pharmaceuticals, Inc. | PURIFIED FORMS OF ROFECOXIB AND METHODS OF MAKING AND USING |
| US20200323830A1 (en) * | 2019-04-09 | 2020-10-15 | Tremeau Pharmaceuticals, Inc. | Treatment of viral hemorrhagic fevers with etoricoxib |
| US10945992B1 (en) | 2019-11-13 | 2021-03-16 | Tremeau Pharmaceuticals, Inc. | Dosage forms of rofecoxib and related methods |
| US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| AU1269495A (en) * | 1994-01-10 | 1995-08-01 | Merck Frosst Canada Inc. | Phenyl heterocycles as cox-2 inhibitors |
-
1997
- 1997-05-13 JP JP9542486A patent/JPH11512754A/ja active Pending
- 1997-05-13 BR BR9709097A patent/BR9709097A/pt not_active IP Right Cessation
- 1997-05-13 US US09/180,647 patent/US6063811A/en not_active Expired - Lifetime
- 1997-05-13 AU AU30049/97A patent/AU3004997A/en not_active Abandoned
- 1997-05-13 HU HU9902889A patent/HUP9902889A3/hu unknown
- 1997-05-13 EE EE9800393A patent/EE03746B1/xx not_active IP Right Cessation
- 1997-05-13 CZ CZ19983738A patent/CZ291463B6/cs not_active IP Right Cessation
- 1997-05-13 EA EA199801017A patent/EA001596B1/ru not_active IP Right Cessation
- 1997-05-13 CA CA002254061A patent/CA2254061C/en not_active Expired - Fee Related
- 1997-05-13 SK SK1567-98A patent/SK284330B6/sk unknown
- 1997-05-13 TR TR1998/02345T patent/TR199802345T2/xx unknown
- 1997-05-13 WO PCT/US1997/008041 patent/WO1997044028A1/en not_active Application Discontinuation
- 1997-05-13 CN CNB971963150A patent/CN1140267C/zh not_active Expired - Fee Related
- 1997-05-13 KR KR10-1998-0709239A patent/KR100373622B1/ko not_active IP Right Cessation
- 1997-05-13 EP EP97924688A patent/EP0910368A1/en not_active Withdrawn
- 1997-05-13 NZ NZ332670A patent/NZ332670A/xx unknown
- 1997-05-13 IL IL12689997A patent/IL126899A/en not_active IP Right Cessation
- 1997-05-14 DZ DZ970087A patent/DZ2200A1/fr active
- 1997-05-14 AR ARP970102021A patent/AR012014A1/es unknown
- 1997-05-15 PE PE1997000379A patent/PE66998A1/es not_active Application Discontinuation
- 1997-05-16 ID IDP971640A patent/ID16921A/id unknown
- 1997-05-16 HR HR9612063.9A patent/HRP970262A2/xx not_active Application Discontinuation
- 1997-05-16 CO CO97026568A patent/CO5050370A1/es unknown
- 1997-05-16 MY MYPI97002138A patent/MY116201A/en unknown
-
1998
- 1998-11-10 IS IS4891A patent/IS4891A/is unknown
- 1998-11-16 NO NO985342A patent/NO985342D0/no not_active Application Discontinuation
- 1998-12-08 BG BG103000A patent/BG103000A/xx unknown
-
1999
- 1999-01-11 PL PL97329940A patent/PL188649B1/pl not_active IP Right Cessation
-
2000
- 2000-02-02 HK HK00100645A patent/HK1021623A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1021623A1 (en) | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases. | |
| AU698509B2 (en) | Compositions for the treatment of rheumatoid-based arthritic diseases | |
| HK1023119A1 (en) | Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases | |
| IL115470A (en) | Therapeutic food composition | |
| AU2935597A (en) | Therapeutic treatment for vegf related diseases | |
| AU3107197A (en) | Medicinal compositions for treating liver diseases | |
| AU2027495A (en) | Pharmaceutical composition for treating hemorrhoidal diseases | |
| HUP9901303A3 (en) | A pharmaceutical composition for the treatment of autoimmune diseases | |
| HUP0000954A3 (en) | Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy | |
| AU4215499A (en) | Treatment of neurodegenerative diseases | |
| ZA977874B (en) | Pharmaceutical compositions for treating viral diseases | |
| IL121329A0 (en) | A pharmaceutical composition for the treatment of cancer | |
| AU3122597A (en) | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases | |
| AU2754997A (en) | The treatment of plant diseases | |
| AUPN221195A0 (en) | Combined waste treatment | |
| ZA974206B (en) | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases. | |
| AUPN727595A0 (en) | Therapeutic compositions | |
| GB9612063D0 (en) | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases | |
| AU5854799A (en) | Novel treatment of neurodegenerative diseases | |
| GB9612065D0 (en) | Compositions for a once a day treatment of cyclooxtgenase-2 mediated diseases | |
| AU8242398A (en) | Medicinal compositions for treating immunodeficiency diseases | |
| AU7190496A (en) | Therapeutic compositions | |
| AU7545998A (en) | Treatment of osteoporosis | |
| AU679162B3 (en) | Therapeutic compositions | |
| ZA9710874B (en) | New therapeutic application of a derivative of thienylcyclohexylamine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080513 |